Inform individuals working with these concomitant medications of the risk of hypoglycemia and educate them about the signs and signs or symptoms of hypoglycemiaJust like other GLP-1 receptor agonists, semaglutide should not be used as first-line remedy as a consequence of a possible possibility of thyroid cancer, based on animal studies.copyright®